NCT05568030

Brief Summary

This study is a double-blinded randomized controlled trial with two arms, comparing a recorded mindfulness intervention to a control psycho-education audio. It is a monocentric study that will take place in Centre Hospitalier Universitaire Vaudois (CHUV), a primary teaching hospital in Lausanne, Switzerland. Patients will be randomized 1:1 to the brief mindfulness intervention vs neutral audio intervention. The investigators involved in recruitment and testing will be blind to the intervention condition. A collaborator that is not involved in this study will prepare a coded randomized sequence of audio assignments, uploaded in Redcap. The audio will be played on a laptop or mp-player with a noise cancelling headset.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 1, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 5, 2022

Completed
23 days until next milestone

Study Start

First participant enrolled

October 28, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2024

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 6, 2025

Status Verified

March 1, 2025

Enrollment Period

2.1 years

First QC Date

September 1, 2022

Last Update Submit

March 3, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Perceived stress reactivity

    The primary outcome is the variation of perceived stress level along the task. A 2-way repeated-measures ANOVA will be conducted to compare the stress reactivity of patients receiving the mindfulness intervention and the control intervention. Perceived stress will be measured using visual analog scales from 0 to 10, 0 meaning no stress perceived and 10 meaning the highest stress perceived.

    Within 3 hours

Secondary Outcomes (7)

  • Heart rate variability

    Within 3 hours

  • Respiration rate

    Within 3 hours

  • Oxygen saturation

    Within 3 hours

  • Electrodermal activity

    Within 3 hours

  • Cerebral activity

    Within 3 hours

  • +2 more secondary outcomes

Study Arms (2)

Mindfulness

EXPERIMENTAL
Behavioral: Mindfulness

Psycho-education

ACTIVE COMPARATOR
Behavioral: Psycho-education

Interventions

MindfulnessBEHAVIORAL

One session of a 20 minute mindfulness recording, based on standardised script, focused on stress management.

Mindfulness

One session of a 20 minute recording, based on standardised script, focused on psychophysiological stress response description.

Psycho-education

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • We plan to recruit adult female patients (\>18 years old) suffering from fibromyalgia (FMS), with chronic pain (more than 6 months), willing and able to give informed consent. Specifically, patients must fulfil the criteria of the American College of Rheumatology (2010) by having the following combination of scores at the widespread pain index (WPI) and the severity score (SS) :
  • WPI score is ≥7 and the SS score is ≥ 5 OR
  • WPI score is comprised between 3 to 6 and the SS score ≥9
  • And no other condition explaining the painful syndrome

You may not qualify if:

  • Insufficient French language skills
  • Unstable psychiatric co-morbidity: major depression with current suicidal risk, unstable psychotic disorder, unstable psychotropic medication (stable=more than 3 month under the same dose).
  • Somatic co-morbidity that could interfere with physiological monitoring/stress tolerance: such as cardiac malformation, recent myocardial dysfunction, cardiac transplantation, or cardiac treatment (pacemaker, antiarrhythmic drugs, muscarinic receptor blockers, ACE inhibitors or any that would induce a modification in HR)
  • Contraindication to sensors positioning (local skin damage or allergies)
  • Substance use disorder (alcohol, drugs).
  • Refusal to listen to an audio recording of mindfulness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre de Médecine Intégrative et Complémentaire, CHUV

Lausanne, Canton of Vaud, 1011, Switzerland

Location

MeSH Terms

Conditions

Fibromyalgia

Interventions

Mindfulness

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

Cognitive Behavioral TherapyBehavior TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Chantal Berna, Prof

    Centre de médecine intégrative et complémentaire, CHUV

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 1, 2022

First Posted

October 5, 2022

Study Start

October 28, 2022

Primary Completion

December 20, 2024

Study Completion

December 31, 2024

Last Updated

March 6, 2025

Record last verified: 2025-03

Locations